MTOR and ovarian carcinoma: The PI3K/Akt/mTOR pathway is altered in approximately 70% of ovarian-cancer cases, leading to enhanced cellular growth, proliferation, and survival, through an intricate series of hyperactive signaling cascades [35,36].